SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (1568)2/11/1999 10:03:00 PM
From: Pluvia  Read Replies (2) | Respond to of 2135
 
<<<The experiments either don't work because the underlying hypothesis is wrong, or the experiment wasn't done properly.>>>

Wrong.

The experiment couldnt be reproduced because the compound was to volatile. Volatile compounds don't make good commercial compounds thus the BYM departure from the ENMD party.

Heck scientists can make drinking water from sea water, but not economically. Science is full of unviable discoveries - interesting for cocktail conversation just don't buy them as investments.

Cheers Steve



To: Henry Niman who wrote (1568)2/11/1999 10:05:00 PM
From: Anthony@Pacific  Read Replies (2) | Respond to of 2135
 
OK HENRY ..you are the designated guru of mice cancer..



To: Henry Niman who wrote (1568)2/11/1999 10:32:00 PM
From: LTK007  Read Replies (1) | Respond to of 2135
 
Henry,much as I HATE to validate Pluvia--his remark regards volatilty
regards the molecule is the drift of the BMY press release---they had to move the NCI test to Boston because the molecule's instabillty was probably what screwed the test at NCI as the transporting was too "stimulating"---the volatility problem I think still remains.Max90